Case Demonstrations in Congenital and Acquired Long QT Syndrome. Can You Make A Correct ECG Interpretation? Zhang, Li  English HTML version    English PDF version   中文 HTML version    中文 PDF version

	Drug-induced LQT-Syndrome: Sotalol-Experience, Heart failure, Susceptibility to drug induced LQT Kaab, Stefan  HTML version    PDF version

	Relationship Among Amiodarone, New Class III Antiarrhytmics, Miscellaneous Agents and Acquired Long QT Syndrome Pérez Riera, Andrés  HTML version    PDF version

	Pharmacogenetics of Drug-Induced Sudden Cardiac Arrest Ackerman, Michael  HTML version    PDF version

	ECG restitution of the beat-to-beat QT-TQ intervals in humans. Can we begin assess arrhythmia vulnerability? Fossa, Anthony  PDF version    PPT version with sound (22 Mb)

	Short QT Interval and Drugs Gussak, Ihor  HTML version    PDF version

	Pacing in Drug Testing Savelieva, Irina  HTML version    PDF version

	Ion channel Genes and Propensity to TdP Priori, Silvia  HTML version    PDF version

	The Holter bin approach and beyond Maison-Blanche, Pierre / Badilini, Fabio  HTML version    PDF version

	QT Variability: Risk Stratification and Drug Studies Haigney, Mark  PDF version    PPT version with sound (12 Mb)    Access to Webcast

	Drug-Induced Torsade de Pointes: Regulatory Evolution Wheeler, William  HTML version    PDF version

	Predicting Drug-HERG Interactions Campbell, Terry  HTML version    PDF version

	QT Interval Dynamicity Methods of Analysis and Clinical Application Locati, Emanuela  HTML version    PDF version

	Mechanistic Evaluation of the Potential Proarrhythmic Effect of QT Prolonging Drugs - “QT Liability” Belardinelli, Luiz  HTML version    PDF version

	ECG Core Laboratory Approach to Drug testing Narula, Dhiraj  HTML version    PDF version

	hERG channel function in LQT2 and drug induced conditions Sanguinetti, Michael  HTML version    PDF version

	Heart Rate Correction of the QT interval Malik, Marek  HTML version    PDF version

	Antibiotics and acquired long QT syndrome: advice for the prescriber Richard J. Kovacs / Bilal R Khan  HTML version    PDF version

	What QT prolongation is of concern? Considerations from the drug development perspective Darpö, Börje  HTML version    PDF version

	Pharmacogenomics of Drug-Induced Conditions Roden, Dan  HTML version    PDF version

	Is QT Prolonged or Shortened? Normal Limits Rautaharju, Pentti  English HTML version    English PDF version   中文 HTML version    中文 PDF version

	Antipsychotic Drugs, QT Interval Prolongation, and Torsades de Pointes Zareba, Wojciech  HTML version    PDF version

	Beyond QT Prolongation in Drug Studies Couderc, Jean-Philippe  HTML version    PDF version    Slides Comments (PDF version)   中文 HTML version    中文 PDF version

	Electrophysiological Mechanism of Drug-Induced Long QT and Torsade de Pointes Role of Genetic Factors El-Sherif, Nabil  HTML version    PDF version

	How to Measure QT Goldenberg, Ilan  English HTML version    English PDF version    中文 HTML version     中文 PDF version

	Managing the Safety of Drugs for Atrial Fibrillation Daubert, James  English HTML version    English PDF version   中文 HTML version    中文 PDF version

	QT Measurements on-screen Methods Badilini, Fabio  English HTML version    Ensglish PDF version   中文 HTML version    中文 PDF version

	Drug Induced QT Prolongation - lecture Zareba, Wojciech  HTML version    PDF version

	Drug Induced QT Prolongation - publication Zareba, Wojciech  PDF version    www.cardiologyjournal.org

	LQTS As A Paradigm for Drug-induced QT Prolongation Moss, Arthur  HTML version    PDF version

	Drug-Induced Spatial Dispersion of Repolarization Antzelevitch, Charles  HTML version    PDF version

	ECG Measurement of QT Interval Kligfield, Paul  HTML version    PDF version

	Assessing QT Liability in Oncology Drug Development Wheeler, William  HTML version    PDF version